Skip to main content
Premium Trial:

Request an Annual Quote

Tech Transfer to the People

"Clickstart a revolution," reads the homepage of Marblar, a new technology transfer-focused online community that aims to connect scientists' discoveries to investors and funds. At Wired's Social Dimenson blog, the Ewing Marion Kauffman Foundation's Samuel Arbesman, who advises Marblar, says that "while there are many startups that catalyze science… Marblar aims to catalyze the process of finding commercial uses for innovation." Arbesman adds that "Marblar acts like a reverse Innocentive [a crowdsourcing-based, problem-solving online community]. Where Innocentive sets scientific and technical challenges and rewards the best of the crowd-sourced solutions, Marblar starts with solutions — the technologies — and rewards those who can find the problems these technologies can solve."

Marblar is soliciting early-access participants at its website. "You might be a current scientist, a recovering scientist, or just a creative mind. Science is great, but the path to move scientific discoveries forward isn't always obvious, and it's harder still when only a couple of people are involved in that conversation," the company says. "That's why we built Marblar — to connect dormant ideas with brilliant people."

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.